OCLN and multiple sclerosis: Alterations in the regulation of occludin and consequent disruption of tight junctions have been associated with a variety of age-associated diseases such as inflammatory bowel disease, multiple sclerosis, cancer, diabetes and allergic disorders [48], [49].